---
figid: PMC4863033__395_2016_558_Fig2_HTML
figtitle: Reperfusion Injury Salvage Kinase (RISK) and Survivor Activating Factor
  Enhancement (SAFE) pathway model of ischaemic conditioning
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC4863033
filename: 395_2016_558_Fig2_HTML.jpg
figlink: /pmc/articles/PMC4863033/figure/Fig2/
number: F2
caption: Reperfusion Injury Salvage Kinase (RISK) and Survivor Activating Factor Enhancement
  (SAFE) pathway model of ischaemic conditioning. The acute ischaemic stress of non-injurious
  ischaemia leads to the release of multiple stress-inducible factors that may activate
  through G-protein coupled receptors (GCPR) or receptor tyrosine kinases (RTK) to
  induce the RISK cascade, or through inflammatory cytokines via the glycoprotein
  130 (gp130) or tumour necrosis factor receptor (TNFR) to activate the SAFE pathway.
  The resulting signalling cascade then impacts upon mitochondria, potentially inhibiting
  the mitochondrial permeability transition pore (mPTP) and other mitochondrial proteins
  such as connexin-43 (Cx43), or via the nucleus to induce, through promotors, new
  protein synthesis. PI3K (Phosphoinositide 3-kinase), Akt [Serine/threonine kinase
  (protein kinase B)], eNOS (Endothelial nitric oxide synthase), ERK (Extracellular
  signal-regulated kinases), JAK (Janus Kinase), MEK (Mitogen-activated protein kinase
  kinase), NO (Nitric oxide), p70S6K (p70 S6 ribosomal protein kinase), PKC (Protein
  Kinase C), Ras/Raf (small GTPase proteins), STAT (Signal transducer and activator
  of transcription)
papertitle: '9th Hatter Biannual Meeting: position document on ischaemia/reperfusion
  injury, conditioning and the ten commandments of cardioprotection.'
reftext: R. M. Bell, et al. Basic Res Cardiol. 2016;111:41.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.92449
figid_alias: PMC4863033__F2
figtype: Figure
redirect_from: /figures/PMC4863033__F2
ndex: 3987614f-debd-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4863033__395_2016_558_Fig2_HTML.html
  '@type': Dataset
  description: Reperfusion Injury Salvage Kinase (RISK) and Survivor Activating Factor
    Enhancement (SAFE) pathway model of ischaemic conditioning. The acute ischaemic
    stress of non-injurious ischaemia leads to the release of multiple stress-inducible
    factors that may activate through G-protein coupled receptors (GCPR) or receptor
    tyrosine kinases (RTK) to induce the RISK cascade, or through inflammatory cytokines
    via the glycoprotein 130 (gp130) or tumour necrosis factor receptor (TNFR) to
    activate the SAFE pathway. The resulting signalling cascade then impacts upon
    mitochondria, potentially inhibiting the mitochondrial permeability transition
    pore (mPTP) and other mitochondrial proteins such as connexin-43 (Cx43), or via
    the nucleus to induce, through promotors, new protein synthesis. PI3K (Phosphoinositide
    3-kinase), Akt [Serine/threonine kinase (protein kinase B)], eNOS (Endothelial
    nitric oxide synthase), ERK (Extracellular signal-regulated kinases), JAK (Janus
    Kinase), MEK (Mitogen-activated protein kinase kinase), NO (Nitric oxide), p70S6K
    (p70 S6 ribosomal protein kinase), PKC (Protein Kinase C), Ras/Raf (small GTPase
    proteins), STAT (Signal transducer and activator of transcription)
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Oamb
  - Tie
  - Ras85D
  - InR
  - wgn
  - Raf
  - ras
  - Ras64B
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - hop
  - bsk
  - Dsor1
  - Mtk
  - Akt
  - Erk7
  - rl
  - Stat92E
  - S6k
  - FZD4
  - NMUR1
  - LPAR3
  - LGR6
  - MRGPRX3
  - MRGPRX4
  - GPR151
  - OXER1
  - GPRC6A
  - MRGPRX1
  - VN1R17P
  - GPR166P
  - GRM1
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - CASR
  - GABBR1
  - GABBR2
  - GPR156
  - GPR158
  - GPR179
  - GPRC5A
  - GPRC5B
  - GPRC5C
  - GPRC5D
  - IL6ST
  - NM
  - LRPPRC
  - TNFRSF1A
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - KRAS
  - HRAS
  - NRAS
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - AKT1
  - AKT2
  - AKT3
  - EPHB2
  - MAPK1
  - MAPK3
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - NOS3
  - ENO4
  - RPS6KB1
  - RPS6KB2
  - GJA1
  - MPTP
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
